FindTrial
Sign In

This study compared PRP and Dexamethasone as interventions for myofascial trigger points in 30 patients. Pain (VAS), trigger sensitivity (PPI), and mouth opening (MIO) were assessed on Day 0, 5, 15, and 1 month to evaluate short and mid-term treatment outcomes.

Comparative Evaluation of Efficacy of Platelet-Rich Plasma (PRP)and Dexamethasone Injections in Myofascial Trigger Points in Masseter (MTrPs) Muscle - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086848
Enrollment
30
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M608- Other myositis

Interventions

Intervention1: Platelet rich plasma: Platelet-rich plasma was prepared from the patients own blood. and 0.5 ml was injected / trigger point Control Intervention1: Platelet rich plasma and Dexamethason

Sponsors

Dr Qazi Saba
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with myofascial pain within the masseter muscle. 2. Patient s consent for participation in this study. 3. Age 18 to 40 years.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone treatment for myofascial pain in the past three months. 2. Patients with any systemic, joint, or muscle disease. 3. Patients with known temporomandibular (bone and disc) disorders or undergoing treatment for the same. 4. Patients with active inflammation or allergies to the skin. 5. Pregnancy/ Lactation. 6. Patients with needle phobia

Design outcomes

Primary

MeasureTime frame
Visual analog score pain pressure index Maximum mouth openingTimepoint: Day 0, Day 5, Day 15 and 1 month—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Qazi Saba

ITS CDSR Murad Nagar, Ghaziabad, Uttar Pradesh.

dr.akshayrathore@its.edu.in06005915391

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026